| Streptococcal Infections and Treatments | Lifetime | 26 | CA 1 | 99.66 |
| Respiratory viral infections research | Lifetime | 53 | CA 2 | 99.72 |
| Pneumonia and Respiratory Infections | Lifetime | 54 | CA 3 | 99.70 |
| COVID-19 Clinical Research Studies | Lifetime | 124 | CA 2 | 99.28 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 52 | CA 2 | 99.64 |
| Influenza Virus Research Studies | Lifetime | 63 | CA 2 | 99.56 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 173 | CA 2 | 99.23 |
| Neonatal and Maternal Infections | Lifetime | 46 | CA 6 | 98.83 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 125 | CA 6 | 99.24 |
| Vaccine Coverage and Hesitancy | Lifetime | 139 | CA 10 | 98.75 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 232 | CA 6 | 98.59 |
| Infection Control and Ventilation | Lifetime | 70 | CA 4 | 98.06 |
| Infection Control in Healthcare | Lifetime | 40 | CA 1 | 98.66 |
| COVID-19 and Mental Health | Lifetime | 382 | CA 18 | 97.09 |
| Antibiotic Use and Resistance | Lifetime | 229 | CA 10 | 98.39 |
| COVID-19 epidemiological studies | Lifetime | 393 | CA 24 | 97.22 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 350 | CA 18 | 97.40 |
| Nosocomial Infections in ICU | Lifetime | 225 | CA 16 | 97.82 |
| Antibiotic Resistance in Bacteria | Lifetime | 881 | CA 37 | 97.68 |
| Urinary Tract Infections Management | Lifetime | 428 | CA 30 | 97.26 |
| COVID-19 and healthcare impacts | Lifetime | 617 | CA 28 | 93.83 |
| SARS-CoV-2 detection and testing | Lifetime | 708 | CA 37 | 91.46 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 328 | CA 12 | 92.46 |
| COVID-19 Impact on Reproduction | Lifetime | 982 | CA 48 | 85.58 |
| Otolaryngology and Infectious Diseases | Lifetime | 415 | CA 18 | 86.84 |
| COVID-19 Clinical Research Studies | 2021-2025 | 678 | CA 10 | 97.09 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 777 | CA 20 | 97.00 |
| Respiratory viral infections research | 2021-2025 | 311 | CA 11 | 94.77 |
| SARS-CoV-2 detection and testing | 2021-2025 | 626 | CA 39 | 90.31 |
| Pneumonia and Respiratory Infections | 2021-2025 | 630 | CA 20 | 89.95 |
| Streptococcal Infections and Treatments | 2021-2025 | 308 | CA 13 | 87.26 |
| Influenza Virus Research Studies | 2021-2025 | 790 | CA 32 | 86.53 |
| Neonatal and Maternal Infections | 2021-2025 | 249 | CA 11 | 80.89 |
| Pneumocystis jirovecii pneumonia detection and treatment | 2021-2025 | 706 | CA 23 | 80.95 |
| Infection Control and Ventilation | 2021-2025 | 913 | CA 26 | 74.36 |
| Enterobacteriaceae and Cronobacter Research | 2021-2025 | 730 | CA 15 | 39.31 |
